PATENT CLAIM ANALYSIS

Application Number: 15973506
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2018-09
Patent Classification: ["424", "181100"]

Abstract:
Benzazepine compounds, conjugates, and pharmaceutical compositions for use in the treatment of disease, such as cancer, are disclosed herein. The disclosed benzazepine compounds are useful, among other things, in the treating of cancer and modulating TLR8. Additionally, benzazepine compounds incorporated into a conjugate with an antibody construct are described herein.

Claim (Index 10):
The compound or salt of  claim 3 , wherein L 3  is a cleavable linker.

Metadata:
- Claim Count in Document: 41.0
- Percentile: 93.0
- Lexical Diversity: 1.5
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15774262', '15509989', '15829604', '13397195', '14112027']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7472782735479082
- 35 USC 102 Novelty (BERT): 0.6126758321592628
- Combined Prediction Score: 0.7338180294090437
- Mean Citation Score: 398.972402
- Max Citation Score: 534.74475
- Similarity Product: 496.4724419046788

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test